Beurs gesloten -
Japan Exchange
08:00:00 10-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
84
JPY
|
0,00%
|
|
-2,33%
|
-22,22%
|
Fiscaal tijdperk: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
9.867
|
9.569
|
5.513
|
10.159
|
5.997
|
6.710
|
Bedrijfswaarde
1 |
7.688
|
8.157
|
3.513
|
4.321
|
1.296
|
2.385
|
K/w-verhouding
|
-12,6
x
|
-11,4
x
|
-5,86
x
|
-7,88
x
|
-3,5
x
|
-3,54
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
154
x
|
1.367
x
|
45,6
x
|
112
x
|
75
x
|
103
x
|
Bedrijfswaarde/omzet
|
120
x
|
1.165
x
|
29
x
|
47,5
x
|
16,2
x
|
36,7
x
|
Bedrijfswaarde/EBITDA
|
-8,79
x
|
-9,04
x
|
-3,92
x
|
-3,56
x
|
-0,75
x
|
-1,34
x
|
Bedrijfswaarde/FCF
|
-14,8
x
|
-13,3
x
|
-5,14
x
|
-5,69
x
|
-1,38
x
|
-1,97
x
|
FCF Yield
|
-6,76%
|
-7,52%
|
-19,5%
|
-17,6%
|
-72,4%
|
-50,8%
|
Price to Book
|
4,46
x
|
6,46
x
|
2,43
x
|
1,69
x
|
1,28
x
|
1,53
x
|
Aantal aandelen (in duizenden)
|
14.136
|
14.390
|
17.556
|
27.909
|
28.559
|
35.693
|
Referentieprijs
2 |
698,0
|
665,0
|
314,0
|
364,0
|
210,0
|
188,0
|
Datum van publicatie
|
29/06/18
|
28/06/19
|
31/07/20
|
30/06/21
|
29/06/22
|
28/06/23
|
Fiscaal tijdperk: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
64
|
7
|
121
|
91
|
80
|
65
|
EBITDA
1 |
-875
|
-902
|
-897
|
-1.214
|
-1.734
|
-1.787
|
Bedrijfsresultaat (EBIT)
1 |
-900
|
-929
|
-914
|
-1.240
|
-1.749
|
-1.787
|
Operationele Marge
|
-1.406,25%
|
-13.271,43%
|
-755,37%
|
-1.362,64%
|
-2.186,25%
|
-2.749,23%
|
Resultaat voor belastingen (EBT)
1 |
-752
|
-835
|
-854
|
-1.186
|
-1.683
|
-1.652
|
Nettowinst (verlies)
1 |
-753
|
-836
|
-855
|
-1.187
|
-1.684
|
-1.653
|
Nettomarge
|
-1.176,56%
|
-11.942,86%
|
-706,61%
|
-1.304,4%
|
-2.105%
|
-2.543,08%
|
WPA
2 |
-55,60
|
-58,17
|
-53,62
|
-46,16
|
-59,92
|
-53,14
|
Free Cash Flow
1 |
-519,5
|
-613,6
|
-683,2
|
-759
|
-939,1
|
-1.211
|
FCF-marge
|
-811,72%
|
-8.766,07%
|
-564,67%
|
-834,07%
|
-1.173,91%
|
-1.862,88%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29/06/18
|
28/06/19
|
31/07/20
|
30/06/21
|
29/06/22
|
28/06/23
|
Fiscaal tijdperk: March |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Omzet
|
3
|
4
|
5
|
2
|
2
|
3
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-400
|
-563
|
-778
|
-348
|
-632
|
-927
|
-585
|
-338
|
-581
|
-248
|
Operationele Marge
|
-13.333,33%
|
-14.075%
|
-15.560%
|
-17.400%
|
-31.600%
|
-30.900%
|
-
|
-
|
-
|
-
|
Resultaat voor belastingen (EBT)
1 |
-398
|
-587
|
-767
|
-346
|
-612
|
-878
|
-597
|
-334
|
-554
|
-247
|
Nettowinst (verlies)
1 |
-399
|
-588
|
-767
|
-347
|
-613
|
-878
|
-598
|
-334
|
-554
|
-248
|
Nettomarge
|
-13.300%
|
-14.700%
|
-15.340%
|
-17.350%
|
-30.650%
|
-29.266,67%
|
-
|
-
|
-
|
-
|
WPA
2 |
-25,91
|
-25,01
|
-27,51
|
-12,35
|
-21,47
|
-30,77
|
-19,10
|
-9,390
|
-15,55
|
-6,950
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12/11/19
|
12/11/20
|
9/11/21
|
14/02/22
|
9/08/22
|
11/11/22
|
10/02/23
|
10/08/23
|
13/11/23
|
13/02/24
|
Fiscaal tijdperk: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
2.179
|
1.412
|
2.000
|
5.838
|
4.701
|
4.325
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-520
|
-614
|
-683
|
-759
|
-939
|
-1.211
|
ROE (netto-inkomsten/eigen vermogen)
|
-32,3%
|
-45,1%
|
-46,7%
|
-29%
|
-31,5%
|
-36,4%
|
ROA (netto-inkomsten/totale activa)
|
-23,3%
|
-23,7%
|
-23,6%
|
-18,5%
|
-19,7%
|
-23,4%
|
Totale activa
1 |
3.227
|
3.524
|
3.621
|
6.424
|
8.529
|
7.057
|
Nettoactief per aandeel
2 |
157,0
|
103,0
|
129,0
|
215,0
|
164,0
|
123,0
|
Cashflow per aandeel
2 |
111,0
|
98,20
|
95,00
|
120,0
|
102,0
|
79,20
|
Capex
1 |
14
|
16
|
46
|
1
|
10
|
23
|
Capex/omzet
|
21,88%
|
228,57%
|
38,02%
|
1,1%
|
12,5%
|
35,38%
|
Datum van publicatie
|
29/06/18
|
28/06/19
|
31/07/20
|
30/06/21
|
29/06/22
|
28/06/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -22,22% | 19,49 mln. | | +3,91% | 109 mld. | | +10,87% | 105 mld. | | +1,28% | 22,25 mld. | | -13,14% | 22,09 mld. | | -7,05% | 18,68 mld. | | -38,36% | 17,58 mld. | | -10,66% | 16,85 mld. | | +3,75% | 13,76 mld. | | +36,70% | 12,46 mld. |
Biotherapeutische geneesmiddelen
|